Stock CGEM CULLINAN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Cullinan Therapeutics, Inc.

Equities

CGEM

US2300311063

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
23.5 USD +3.12% Intraday chart for Cullinan Therapeutics, Inc. -2.61% +130.62%
Jun. 01 Cullinan Therapeutics, Inc. Announces Positive Initial Data from Pivotal Phase 2b Rezil1 Study of Zipalertinib CI
May. 15 Cullinan Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
6c3b2f2065e98b9c174566c01d7ae.HDd7Q5EPhjDBd0ZyWGhHHm3iKQmJzHUXvuvwRmPa0eQ.fQQaKdxizVStBDUHFjwtZjmVfzzP-R4kiLzELDXrlr53ZUMg8H_EXqYZEw~cc3ce2f1bb82b9190cdc9524de387ad7
  1. Stock Market
  2. Equities
  3. CGEM Stock
  4. Charts Cullinan Therapeutics, Inc.
  5. News Chart